Bausch Health Companies Inc (BHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -208,193 | 176,455 | 199,904 | 195,539 | 203,940 |
| Depreciation Amortization | 275,976 | 137,665 | 85,179 | 81,600 | 107,870 |
| Income taxes - deferred | -55,403 | -16,000 | -90,000 | N/A | N/A |
| Accounts receivable | 25,187 | -26,998 | 26,654 | 18,052 | N/A |
| Accounts payable and accrued liabilities | -52,185 | 30,771 | -6,135 | 3,273 | N/A |
| Other Working Capital | -21,864 | -10,382 | 40,101 | -25,065 | -10,850 |
| Other Operating Activity | 299,673 | 69,386 | -51,378 | 67,454 | 220,990 |
| Operating Cash Flow | $263,191 | $360,897 | $204,325 | $340,853 | $521,950 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,777 | 20,879 | -21,999 | -35,086 | -44,800 |
| Net Acquisitions | 308,982 | N/A | -101,920 | N/A | 0 |
| Purchase Of Investment | N/A | -3,823 | -6,290 | -35,910 | N/A |
| Sale Of Investment | 7,965 | 1,078 | 29,666 | 55,951 | N/A |
| Purchase Sale Intangibles | -84,532 | -761,829 | N/A | N/A | N/A |
| Other Investing Activity | -86,231 | -760,906 | -7,288 | 0 | 4,360 |
| Investing Cash Flow | $228,939 | $-742,772 | $-107,831 | $-15,045 | $-40,440 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 992,400 | 480,000 | 0 | N/A | N/A |
| Debt Repayment | -791,816 | -130,000 | 0 | -418,344 | N/A |
| Common Stock Issued | 58,425 | 866 | 0 | 11,217 | N/A |
| Common Stock Repurchased | -60,130 | N/A | -29,842 | N/A | N/A |
| Dividend Paid | -356,291 | -147,146 | -180,287 | -321,523 | -80,060 |
| Other Financing Activity | -55,871 | -26,673 | -182 | 0 | -12,190 |
| Financing Cash Flow | $-213,283 | $177,047 | $-210,311 | $-728,650 | $-92,250 |
| Exchange Rate Effect | 959 | 1,744 | -2,277 | 1,943 | -5 |
| Beginning Cash Position | 114,463 | 317,547 | 433,641 | 834,540 | 445,280 |
| End Cash Position | 394,269 | 114,463 | 317,547 | 433,641 | 834,540 |
| Net Cash Flow | $279,806 | $-203,084 | $-116,094 | $-400,899 | $389,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | 263,191 | 360,897 | 204,325 | 340,853 | 521,950 |
| Capital Expenditure | -16,823 | -7,423 | -21,999 | -35,086 | N/A |
| Free Cash Flow | 246,368 | 353,474 | 182,326 | 305,767 | 521,950 |